Cellectis Tech Stack

Cellectis uses 8 technology products and services including Linkedin Insight Tag, ExpressionEngine, Microsoft 365, and more. Explore Cellectis's tech stack below.

  • Linkedin Insight Tag
    Analytics
  • ExpressionEngine
    Content Management System
  • Microsoft 365
    Email
  • jQuery
    Javascript Libraries
  • Microsoft
    Miscellaneous
  • MacOS
    Operating Systems & Computing Languages
  • PHP
    Programming Languages
  • VMware
    Virtualisation Software

Media & News

Cellectis's Email Address Formats

Cellectis uses at least 4 format(s):
Cellectis Email FormatsExamplePercentage
first.last@cellectis.comJohn.Doe@cellectis.com
84%
flast@cellectis.comJDoe@cellectis.com
12%
last@cellectis.comDoe@cellectis.com
2%
first.middle@cellectis.comJohn.Michael@cellectis.com
2%

Frequently Asked Questions

Where is Cellectis's headquarters located?

Minus sign iconPlus sign icon
Cellectis's main headquarters is located at Biopark - 8 rue de la Croix Jarry Paris, 75013 FR. The company has employees across 2 continents, including EuropeNorth America.

What is Cellectis's phone number?

Minus sign iconPlus sign icon
You can contact Cellectis's main corporate office by phone at +33-1-81-69-16-00. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Cellectis's stock symbol?

Minus sign iconPlus sign icon
Cellectis is a publicly traded company; the company's stock symbol is CLLS.

What is Cellectis's official website and social media links?

Minus sign iconPlus sign icon
Cellectis's official website is cellectis.com and has social profiles on LinkedIn.

How much revenue does Cellectis generate?

Minus sign iconPlus sign icon
As of April 2024, Cellectis's annual revenue reached $35M.

What is Cellectis's SIC code NAICS code?

Minus sign iconPlus sign icon
Cellectis's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Cellectis have currently?

Minus sign iconPlus sign icon
As of April 2024, Cellectis has approximately 235 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: A. C.Chief Executive Officer: G. P.Chief Scientific Officer: P. D.. Explore Cellectis's employee directory with LeadIQ.

What industry does Cellectis belong to?

Minus sign iconPlus sign icon
Cellectis operates in the Biotechnology Research industry.

What technology does Cellectis use?

Minus sign iconPlus sign icon
Cellectis's tech stack includes Linkedin Insight TagExpressionEngineMicrosoft 365jQueryMicrosoftMacOSPHPVMware.

What is Cellectis's email format?

Minus sign iconPlus sign icon
Cellectis's email format typically follows the pattern of first.last@cellectis.com. Find more Cellectis email formats with LeadIQ.

How much funding has Cellectis raised to date?

Minus sign iconPlus sign icon
As of April 2024, Cellectis has raised $80M in funding. The last funding round occurred on Nov 01, 2023.

When was Cellectis founded?

Minus sign iconPlus sign icon
Cellectis was founded in 1999.
Cellectis

Cellectis

Biotechnology ResearchParis, France51-200 Employees

Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 24 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its proprietary gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells.

As part of its commitment to a cure, Cellectis remains dedicated to its goal of providing life-saving UCART product candidates to address unmet needs for multiple cancers including B-cell acute lymphoblastic leukemia (B-ALL), non-Hodgkin lymphoma (NHL) and acute myeloid leukemia (AML).

Cellectis headquarters are in Paris, France, with additional locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS).

To find out more about us, visit our website: www.cellectis.com. To learn more about our community guidelines, visit: http://www.cellectis.com/en/social-media-guidelines/

Follow our other social media accounts: @cellectis on Twitter and Cellectis YouTube

TALEN® is a registered trademark owned by the Cellectis Group.

Section iconCompany Overview

Headquarters
Biopark - 8 rue de la Croix Jarry Paris, 75013 FR
Phone number
+33-1-81-69-16-00
SIC Code
8731 - Commercial Physical and Biological Research
Stock Symbol
CLLS
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
1999
Employees
51-200

Section iconFunding & Financials

  • $80M

    Cellectis has raised a total of $80M of funding over 8 rounds. Their latest funding round was raised on Nov 01, 2023.

  • $10M$50M

    Cellectis's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $80M

    Cellectis has raised a total of $80M of funding over 8 rounds. Their latest funding round was raised on Nov 01, 2023.

  • $10M$50M

    Cellectis's revenue is in the range of $10M$50M

© LeadIQ, Inc. All rights reserved.